Michael Thomas Henderson Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

Michael Thomas Henderson is Director of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 105,379 shares of AGLE, which is worth approximately $2.91 Million. The most recent transaction as insider was on Jan 10, 2025, when has been sold 105,379 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K

n/a 3M change

n/a 12M change

Total Value Held $2.91 Million

MICHAEL THOMAS HENDERSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 10 2025	BUY Other acquisition or disposition	-	105,379 Added 50.0%	105,379 Common Stock

Also insider at

BBIO

BridgeBio Pharma, Inc. Healthcare

Chief Business Officer

ARYD

ARYA Sciences Acquisition Corp IV Financial Services

APGE

Apogee Therapeutics, Inc.

Chief Executive Officer

MTH